Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-16
2011-08-16
Havlin, Robert (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S416000
Reexamination Certificate
active
07999119
ABSTRACT:
Compounds of general formula (I) wherein R is phenyl optionally substituted with one or more halo substituents; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.
REFERENCES:
patent: 5641800 (1997-06-01), Bach et al.
patent: 6214991 (2001-04-01), Jones et al.
patent: 7582672 (2009-09-01), Middlemiss et al.
patent: 7750027 (2010-07-01), Armer et al.
patent: 2009/0018138 (2009-01-01), Middlemiss et al.
patent: 2009/0018139 (2009-01-01), Middlemiss et al.
patent: 2009/0018338 (2009-01-01), Middlemiss et al.
patent: 2009/0023788 (2009-01-01), Middlemiss et al.
patent: 2009/0192195 (2009-07-01), Armer et al.
patent: 2010/0022613 (2010-01-01), Armer et al.
patent: 2010/0041699 (2010-02-01), Boyd et al.
patent: 2010/0266535 (2010-10-01), Armer et al.
patent: 2010/0330077 (2010-12-01), Armer et al.
patent: 1 505 061 (2005-02-01), None
patent: WO 2005/044260 (2005-05-01), None
patent: WO 2009/077728 (2009-06-01), None
Unpublished U.S. Appl. No. 12/779,638, filed May 13, 2010; inventors: Hunter et al., U.S. Patent and Trademark Office, Alexandria, Virginia.
Unpublished U.S. Appl. No. 13/014,314, filed Jan. 26, 2011; inventors: Armer et al., U.S. Patent and Trademark Office, Alexandria, Virginia.
Unpublished U.S. Appl. No. 13/017,860, filed Jan. 31, 2011; inventors: Armer et al., U.S. Patent and Trademark Office, Alexandria, Virginia.
Armer Richard Edward
Dorgan Colin Richard
Johnson Peter David
Wynne Graham Michael
Havlin Robert
Oxagen Limited
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Compounds having CRTH2 antagonist activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having CRTH2 antagonist activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having CRTH2 antagonist activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679763